199 related articles for article (PubMed ID: 10207054)
21. Multiple basic-leucine zipper proteins regulate induction of the mouse heme oxygenase-1 gene by arsenite.
Gong P; Stewart D; Hu B; Vinson C; Alam J
Arch Biochem Biophys; 2002 Sep; 405(2):265-74. PubMed ID: 12220541
[TBL] [Abstract][Full Text] [Related]
22. C/EBP family transcription factors are degraded by the proteasome but stabilized by forming dimer.
Hattori T; Ohoka N; Inoue Y; Hayashi H; Onozaki K
Oncogene; 2003 Mar; 22(9):1273-80. PubMed ID: 12618752
[TBL] [Abstract][Full Text] [Related]
23. DNA targets for certain bZIP proteins distinguished by an intrinsic bend.
Paolella DN; Palmer CR; Schepartz A
Science; 1994 May; 264(5162):1130-3. PubMed ID: 8178171
[TBL] [Abstract][Full Text] [Related]
24. Amino-terminal-derived JNK fragment alters expression and activity of c-Jun, ATF2, and p53 and increases H2O2-induced cell death.
Buschmann T; Yin Z; Bhoumik A; Ronai Z
J Biol Chem; 2000 Jun; 275(22):16590-6. PubMed ID: 10748185
[TBL] [Abstract][Full Text] [Related]
25. Dimerization specificity of the leucine zipper-containing bZIP motif on DNA binding: prediction and rational design.
Vinson CR; Hai T; Boyd SM
Genes Dev; 1993 Jun; 7(6):1047-58. PubMed ID: 8504929
[TBL] [Abstract][Full Text] [Related]
26. Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis.
van Dam H; Castellazzi M
Oncogene; 2001 Apr; 20(19):2453-64. PubMed ID: 11402340
[TBL] [Abstract][Full Text] [Related]
27. Intramolecular inhibition of activating transcription factor-2 function by its DNA-binding domain.
Li XY; Green MR
Genes Dev; 1996 Mar; 10(5):517-27. PubMed ID: 8598283
[TBL] [Abstract][Full Text] [Related]
28. Mutual regulation of c-Jun and ATF2 by transcriptional activation and subcellular localization.
Liu H; Deng X; Shyu YJ; Li JJ; Taparowsky EJ; Hu CD
EMBO J; 2006 Mar; 25(5):1058-69. PubMed ID: 16511568
[TBL] [Abstract][Full Text] [Related]
29. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway.
Huang LE; Gu J; Schau M; Bunn HF
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):7987-92. PubMed ID: 9653127
[TBL] [Abstract][Full Text] [Related]
30. Characterization and functional analysis of cAMP response element modulator protein and activating transcription factor 2 (ATF2) isoforms in the human myometrium during pregnancy and labor: identification of a novel ATF2 species with potent transactivation properties.
Bailey J; Phillips RJ; Pollard AJ; Gilmore K; Robson SC; Europe-Finner GN
J Clin Endocrinol Metab; 2002 Apr; 87(4):1717-28. PubMed ID: 11932306
[TBL] [Abstract][Full Text] [Related]
31. Autocrine growth and anchorage independence: two complementing Jun-controlled genetic programs of cellular transformation.
van Dam H; Huguier S; Kooistra K; Baguet J; Vial E; van der Eb AJ; Herrlich P; Angel P; Castellazzi M
Genes Dev; 1998 Apr; 12(8):1227-39. PubMed ID: 9553051
[TBL] [Abstract][Full Text] [Related]
32. Induction of CHOP expression by amino acid limitation requires both ATF4 expression and ATF2 phosphorylation.
Averous J; Bruhat A; Jousse C; Carraro V; Thiel G; Fafournoux P
J Biol Chem; 2004 Feb; 279(7):5288-97. PubMed ID: 14630918
[TBL] [Abstract][Full Text] [Related]
33. Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress.
Hayakawa J; Mittal S; Wang Y; Korkmaz KS; Adamson E; English C; Ohmichi M; McClelland M; Mercola D
Mol Cell; 2004 Nov; 16(4):521-35. PubMed ID: 15546613
[TBL] [Abstract][Full Text] [Related]
34. Human Cdc34 and Rad6B ubiquitin-conjugating enzymes target repressors of cyclic AMP-induced transcription for proteolysis.
Pati D; Meistrich ML; Plon SE
Mol Cell Biol; 1999 Jul; 19(7):5001-13. PubMed ID: 10373550
[TBL] [Abstract][Full Text] [Related]
35. HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization.
Wagner S; Green MR
Science; 1993 Oct; 262(5132):395-9. PubMed ID: 8211160
[TBL] [Abstract][Full Text] [Related]
36. Jun and Fos heterodimerize with ATFa, a member of the ATF/CREB family and modulate its transcriptional activity.
Chatton B; Bocco JL; Goetz J; Gaire M; Lutz Y; Kedinger C
Oncogene; 1994 Feb; 9(2):375-85. PubMed ID: 8290251
[TBL] [Abstract][Full Text] [Related]
37. Ubiquitinylation of transcription factors c-Jun and c-Fos using reconstituted ubiquitinylating enzymes.
Hermida-Matsumoto ML; Chock PB; Curran T; Yang DC
J Biol Chem; 1996 Mar; 271(9):4930-6. PubMed ID: 8617766
[TBL] [Abstract][Full Text] [Related]
38. Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein.
Campanero MR; Flemington EK
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2221-6. PubMed ID: 9122175
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicity.
Bhoumik A; Jones N; Ronai Z
Proc Natl Acad Sci U S A; 2004 Mar; 101(12):4222-7. PubMed ID: 15010535
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-1 beta-induced ceramide and diacylglycerol generation may lead to activation of the c-Jun NH2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F.
Welsh N
J Biol Chem; 1996 Apr; 271(14):8307-12. PubMed ID: 8626526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
